Rare diseases
Investigational molecules
Locations
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
PolandA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
PolandPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
PolandEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
PolandBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
PolandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PolandLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PolandBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
PolandA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
PolandA study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis
PolandA study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
PolandA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
